Cell-SELEX: In Vitro Selection of Synthetic Small Specific Ligands
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 1296, 213-224
Abstract
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is an in vitro process enabling selection of nucleic acid molecules binding to target ligands with high binding affinity and specificity. The selection process involves several rounds of two successive steps: (1) binding of the oligonucleotides to the target under stringent conditions and (2) amplification of the target-bound nucleic acids by polymerase chain reaction. Using this strategy, RNA or DNA aptamers are selected upon recognition and binding to specific surface structures of the target. Aptamers generated during the final rounds of selection can be notably used in applications dedicated to diagnosis of diseases or therapeutic approaches.Keywords
This publication has 30 references indexed in Scilit:
- Probing the SELEX Process with Next-Generation SequencingPLOS ONE, 2011
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancerJournal of Controlled Release, 2011
- Selection of RNA aptamers imported into yeast and human mitochondriaRNA, 2010
- CS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2PLOS ONE, 2009
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and TherapyChemical Reviews, 2007
- In vitro selection of DNA aptamers binding ethanolamineBiochemical and Biophysical Research Communications, 2005
- WebLogo: A Sequence Logo Generator: Figure 1Genome Research, 2004
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Sequence logos: a new way to display consensus sequencesNucleic Acids Research, 1990